Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Astronomy Algorithms Help Diagnose Aggressive Tumors

Published: Monday, February 25, 2013
Last Updated: Monday, February 25, 2013
Bookmark and Share
Scientists have honed techniques originally developed to spot distant galaxies and used them to identify biomarkers that signal a cancer’s aggressiveness among some 2,000 breast tumours.

The findings mean that the age-old practice of pathologists looking down the microscope to spot key differences in the staining of tumour samples could one day become a thing of the past.

To develop this new automated approach the researchers, from the Cancer Research UK Cambridge Institute, and the Department of Oncology and the Institute of Astronomy at the University of Cambridge, adapted techniques used by astronomers to automatically pick out indistinct objects in the night sky.

They applied these to immunohistochemistry (IHC), which relies on pathologists being able to distinguish subtle differences in the staining of tumour cells down the microscope, depending on the specific proteins they express.

To road test the new approach they used it to measure the levels of three different proteins linked to more aggressive cancers, across tumour samples from more than 2,000 breast cancer patients.

They compared the accuracy of manually scoring these results, by observing the staining of the tumour samples down the microscope, versus relying on a computer to do this automatically. This showed that the new automated system was at least as accurate as the manual one, whilst at the same time being many times faster.

Study lead author Dr Raza Ali, a pathology fellow from Cancer Research UK’s Cambridge Institute at the University of Cambridge, said: “We’ve exploited the natural overlap between the techniques astronomers use to analyse deep sky images from the largest telescopes and the need to pinpoint subtle differences in the staining of tumour samples down the microscope.

“The results have been even better than we’d hoped, with our new automated approach performing with accuracy comparable to the time-consuming task of scoring images manually, after only relatively minor adjustments to the formula. We’re now planning a larger international study involving samples from more than 20,000 breast cancer patients to further refine our strategy.”

Senior author Professor Carlos Caldas, also from Cancer Research UK’s Cambridge Institute at the University of Cambridge, added:  “Modern techniques are giving us some of the first insights into the key genes and proteins important in predicting the success or failure of different cancer treatments. But before these can be applied in the clinic, their usefulness needs to be verified in hundreds or sometimes thousands of tumour samples. Already this new automated approach means we can now analyse up to 4,000 images a day, helping streamline the process of translating these discoveries into the clinic.”

Dr Nicholas Walton, from Cambridge University’s Institute of Astronomy, said: “It’s great that our image analysis software, which was originally developed to help, for instance, track down planets harbouring life outside of our Solar system, is now also being used to help improve the outlook for cancer patients, much closer to home.”

Dr Julie Sharp, senior science information manager at Cancer Research UK, said: “This unlikely collaboration between astronomers and cancer researchers is a prime example of how, by working together, scientists from different disciplines can bring about innovative new solutions for beating cancer.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Scientists Discover How Cells Overpower Cancer Drug
Cancer Research UK scientists have found how cells adapt to overcome cancer drugs designed to interfere with their genetic controls, according to a recently published study.
Friday, September 18, 2015
Genetic Chaos in Tumours Could Help Predict Chemo Response
Researchers have shown how the level of genetic chaos in tumours could help predict patients’ response to chemotherapy according to new research.
Friday, August 07, 2015
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Tuesday, August 04, 2015
‘Liquid Biopsies’ Could Help Spot Genetic Faults in Lung Cancer
Study analyze blood samples from 97 patients who took part in the EURTAC clinical trial.
Saturday, March 07, 2015
New Companies Join Cancer Research UK Consortium
Three new biomarker companies have been selected to work with the Early Diagnosis Consortium, a collaboration between Cancer Research UK, its commercial arm, Cancer Research Technology and Abcodia.
Thursday, December 11, 2014
Why Bowel Cancer Sometimes Outsmarts Treatment
New study challenges the prevailing view of how bowel cancer develops in the large intestine.
Tuesday, December 02, 2014
Cancer Cell Fingerprints in the Blood May Speed up Childhood Cancer Diagnosis
Researchers found unique molecular fingerprints for 11 types of children’s tumours, to develop blood tests to diagnose these cancers.
Tuesday, November 04, 2014
Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner
Partnership Developed to Trial Immunotherapy Vaccine For Lung Cancer
Friday, September 12, 2014
Cancer Research UK, Astellas Partner on Cancer Treatments
The new collaboration will conduct a two-year research programme in the UK to find promising new drug targets for pancreatic cancer.
Friday, August 08, 2014
New Route to Boost Pancreatic Cancer Treatment
Cancer Research UK scientists have uncovered new insights into how the key pancreatic cancer drug gemcitabine is broken down in tumour cells.
Monday, June 02, 2014
Cancer Research UK, AZ and Pfizer Partner to Advance Lung Cancer Treatment
Partnership creates a pioneering clinical trial for patients with advanced lung cancer, marking a new era of research into personalised medicines to treat cancer.
Thursday, April 17, 2014
Final Results from the Phase III TeloVac Trial in Pancreatic Cancer
Results from the trial showed no significant difference in overall survival between the groups that received the vaccine and the control group receiving chemotherapy.
Tuesday, June 04, 2013
Study Points to Potential New Treatment for Deadly Pancreatic Cancer
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
Tuesday, May 01, 2012
Scientists Find New Drug Target for Hard-to-Treat Leukaemia
Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia – a cancer with limited treatment options and relatively poor survival.
Friday, March 30, 2012
Cancer Research UK Selects Eden Biodesign to Develop and Manufacture two Therapeutic Candidates
Eden Biodesign to provide process development and manufacturing services for two of CR-UK’s gene therapy products for head and neck cancer.
Thursday, September 06, 2007
Scientific News
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
Mathematical Model Helps Show How Zebrafish Get Their Stripes
The iconic yellow and blue stripes of zebrafish form dynamically as young fish develop and grow. A mathematical model developed by Brown University researchers helps to show how pigment cells interact to form the pattern.
Epigenome Influenced by Habitat and Lifestyle
Study on Pygmy hunter-gatherer populations and Bantu farmers in Central Africa shows that habitat and lifestyle can impact the epigenome.
Shining Light on Microbial Growth and Death Inside our Guts
Precise measurement of microbial populations in gastrointestinal tracts could be key to identifying novel therapies.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Biologists Induce Flatworms to Grow Heads and Brains of Other Species
Findings shed light on role of a new kind of epigenetic signaling in evolution, could yield clues for understanding birth defects and regeneration.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos